환자 혈액 관리 시장 규모 : 제품 유형별, 컴포넌트별, 최종 사용자별, 지역별 및 예측별

Patient Blood Management Market Overview

The global patient blood management market, which includes clinical strategies, technologies, and therapeutic approaches used to optimize the care of patients who might need transfusion, is advancing steadily as healthcare systems increasingly focus on improving patient outcomes while reducing dependence on donor blood. Expansion of the market is supported by growing awareness regarding risks associated with allogeneic blood transfusions, rising adoption of evidence-based protocols in surgical and critical care settings, and increasing integration of diagnostic tools and pharmacological therapies that assist clinicians in managing anemia, minimizing blood loss, and improving hemostasis during medical procedures.

Market momentum is further supported by strengthening hospital policies focused on transfusion safety, growing investments in patient-centric treatment models, and wider clinical acceptance of blood conservation techniques such as cell salvage, antifibrinolytic therapy, and point-of-care coagulation testing that enable more efficient utilization of blood resources while improving perioperative care standards.

Market size - VMR Analyst Corridor Approach

A revenue convergence corridor is emerging across recent global assessments instead of relying on a single-point estimate. Market value is consolidating to USD 16 Billion in 2025, while long-term projections are extending toward USD 26 Billion by 2033, reflecting mid-to high-single-digit growth momentum. A CAGR of 6.4% is being recorded over the forecast period (2027-2033), underscoring the market's structurally resilient growth trajectory.

Global Patient Blood Management Market Definition

The patient blood management market refers to the clinical and commercial ecosystem surrounding medical strategies, technologies, and therapeutic solutions used to optimize the management of a patient's own blood during surgical procedures, trauma care, and chronic disease treatment. This market encompasses diagnostic systems, pharmacological agents, surgical devices, and clinical protocols designed to detect anemia, reduce perioperative blood loss, improve coagulation management, and minimize the need for allogeneic blood transfusions across hospitals, specialty clinics, and advanced care centers.

Market dynamics include the adoption of evidence-based treatment frameworks by healthcare providers, the integration of blood conservation technologies into surgical and critical care workflows, and procurement of related therapeutics and monitoring tools through hospital purchasing networks, direct manufacturer supply agreements, and healthcare distribution channels that support continuous implementation of patient-focused blood optimization practices.

Global Patient Blood Management Market Drivers

The market drivers for the patient blood management market can be influenced by various factors. These may include:

Rising Surgical Procedure Volumes Across Healthcare Systems

Growing surgical procedure volumes across healthcare systems are increasing the adoption of patient blood management protocols, as hospitals are prioritizing optimized transfusion practices and perioperative blood conservation strategies. Clinical workflow standardization is supporting protocol integration across surgical departments. Hospital cost containment initiatives are reinforcing reduced transfusion dependence while improving post-operative recovery monitoring frameworks.

Increasing Focus on Transfusion Safety and Clinical Outcomes

Greater focus on transfusion safety and patient outcomes is strengthening the implementation of structured blood management programs across hospitals and surgical centers. Clinical governance frameworks are encouraging restrictive transfusion thresholds and preoperative anemia management. Multidisciplinary coordination across anesthesiology, hematology, and surgery departments is improving treatment planning, supporting consistent adoption of evidence-guided blood utilization strategies.

Rising Prevalence of Anemia and Blood Disorders in Surgical Patients

The growing prevalence of anemia and blood disorders among surgical patients is accelerating demand for patient blood management strategies across healthcare institutions. According to the World Health Organization, anemia is affecting about 1.62 billion people globally, reinforcing the importance of preoperative screening and treatment pathways. Hospitals are integrating anemia correction protocols to stabilize hemoglobin levels before surgical interventions.

Expansion of Hospital Cost Optimization and Resource Efficiency Programs

Hospital cost optimization initiatives are accelerating the adoption of patient blood management frameworks, as healthcare systems are reducing reliance on expensive blood transfusion procedures. Procurement policies are prioritizing conservation technologies and monitoring systems that improve blood utilization efficiency. Value-based healthcare models are encouraging clinical pathways that minimize complications while improving operational efficiency across surgical care units.

Global Patient Blood Management Market Restraints

Several factors act as restraints or challenges for the patient blood management market. These may include:

Limited Standardization of Clinical Implementation Protocols

Limited standardization of clinical implementation protocols is restricting the broader adoption of patient blood management programs across healthcare facilities. Variation in hospital transfusion policies is creating inconsistent protocol execution within surgical departments. Clinical training gaps are slowing the integration of anemia management pathways. Procurement priorities remain uneven, causing uneven deployment of monitoring systems and conservation technologies.

High Implementation and Infrastructure Adjustment Costs

High implementation and infrastructure adjustment costs are limiting the rapid deployment of patient blood management systems within hospitals. Investment requirements for diagnostic tools, staff training programs, and monitoring technologies are increasing operational expenditure. Budget constraints across mid-sized healthcare facilities are slowing adoption. Procurement committees are prioritizing immediate clinical needs over long-term blood conservation investments.

Shortage of Trained Clinical Personnel and Program Awareness

Shortage of trained clinical personnel is slowing structured adoption of patient blood management programs across healthcare systems. Clinical awareness regarding perioperative anemia correction and restrictive transfusion practices remains uneven across many institutions. Training resources are remaining concentrated within advanced hospitals. As a result, operational integration across smaller surgical centers is progressing gradually within existing transfusion-focused workflows.

Global Imbalance in Blood Supply and Donation Infrastructure

Persistent imbalance in blood supply and donation infrastructure is limiting consistent implementation of structured blood management programs. The World Health Organization reports that nearly 40% of global blood donations are collected in high-income countries representing only 16% of the world's population, highlighting uneven availability. Resource limitations across developing healthcare systems are constraining program scalability and monitoring capacity.

Global Patient Blood Management Market Opportunities

The landscape of opportunities within the patient blood management market is driven by several growth-oriented factors and shifting global demands. These may include:

Expansion of Digital Clinical Decision Support Systems

The growing expansion of digital clinical decision support systems is shaping the patient blood management market, as hospitals are integrating transfusion analytics and patient monitoring platforms into perioperative care workflows. Real-time hemoglobin monitoring and predictive analytics are improving transfusion planning accuracy. Data-supported clinical pathways are strengthening hospital compliance with restrictive transfusion protocols while improving surgical outcome management.

Integration Within Value-Based Healthcare Delivery Models

Increasing integration within value-based healthcare delivery models is creating opportunity momentum for patient blood management adoption across healthcare institutions. Hospital reimbursement frameworks are emphasizing outcome-based treatment efficiency. Clinical resource optimization programs are strengthening demand for transfusion reduction strategies. Coordinated care pathways across surgical and hematology teams are reinforcing structured implementation of blood conservation practices.

Growing Government and Institutional Focus on Blood Conservation Programs

Rising government and institutional focus on blood conservation initiatives is expanding opportunities across the patient blood management market. National health agencies are promoting clinical guidelines encouraging restrictive transfusion thresholds and anemia screening programs. According to the World Health Organization, over 118 million blood donations are collected each year globally, strengthening policy attention toward efficient blood utilization strategies.

Advancement of Minimally Invasive Surgical and Blood Monitoring Technologies

Advancement of minimally invasive surgical procedures and advanced blood monitoring technologies is strengthening opportunity potential across the patient blood management market. Surgical innovation is reducing intraoperative blood loss while improving recovery timelines. Integration of point-of-care hemoglobin testing and coagulation monitoring systems is improving surgical decision workflows. Technology-supported blood conservation strategies are strengthening hospital adoption momentum.

Global Patient Blood Management Market Segmentation Analysis

The Global Patient Blood Management Market is segmented based on Product Type, Component, End-User, and Geography.

Patient Blood Management Market, By Product Type

Instruments: Instruments maintain a leading position within the patient blood management market, as hospitals are integrating advanced diagnostic analyzers, hemoglobin monitoring systems, and blood salvage devices to improve perioperative blood conservation practices. Increasing emphasis on real-time patient monitoring and intraoperative blood recovery is supporting procurement across surgical departments. Integration within digital hospital infrastructure is strengthening operational efficiency and clinical decision support during transfusion management.

Accessories: Accessories are witnessing stable demand across the patient blood management market, as components such as transfusion sets, filtration devices, and collection systems are supporting procedural safety and standardized clinical workflows. Continuous utilization during surgical procedures and transfusion preparation maintains consistent procurement cycles. Hospitals are prioritizing disposable and sterile accessory systems to maintain infection control compliance and operational reliability.

Reagents & Kits: Reagents and kits are experiencing substantial growth within the patient blood management market, as diagnostic testing for hemoglobin levels, coagulation profiles, and blood compatibility screening is increasing across clinical laboratories. Expansion of preoperative anemia screening programs is strengthening laboratory testing demand. Diagnostic standardization across hospitals and pathology labs is supporting repeat procurement cycles and strengthening segment growth.

Patient Blood Management Market, By Component

Whole Blood & Red Blood Cells: Whole blood and red blood cells dominate the patient blood management market, as transfusion support during trauma care, surgical interventions, and chronic disease treatment remains a central component of hospital blood utilization practices. Clinical protocols emphasizing optimized transfusion thresholds are maintaining controlled usage across healthcare facilities. Blood banks are coordinating supply stabilization strategies to ensure reliable availability for emergency and surgical applications.

Plasma: Plasma is witnessing increasing utilization within the patient blood management market, as coagulation management and treatment of bleeding disorders require plasma-based transfusion support in critical care settings. Surgical departments are incorporating plasma therapy within trauma stabilization protocols and complex surgical procedures. Growing attention toward balanced transfusion strategies is strengthening the integration of plasma components within modern blood management frameworks.

Patient Blood Management Market, By End-User

Hospitals: Hospitals dominate the patient blood management market, as large surgical volumes and emergency care services require integrated transfusion management systems across perioperative and intensive care environments. Multidisciplinary clinical teams are coordinating anemia correction, blood conservation techniques, and transfusion monitoring within hospital infrastructure. Adoption of structured patient blood management protocols is improving treatment efficiency while supporting optimized blood resource utilization.

Blood Banks: Blood banks maintain a critical position within the patient blood management market, as centralized collection, testing, and storage operations are supporting reliable blood component availability for healthcare institutions. Inventory management systems are improving coordination between hospitals and regional donation centers. Quality assurance procedures and donor screening protocols are strengthening safety standards while maintaining steady distribution of blood products.

Diagnostic Clinics & Pathology Labs: Diagnostic clinics and pathology laboratories are witnessing steady growth in the patient blood management market, as laboratory screening for anemia, coagulation disorders, and blood compatibility testing is expanding across healthcare networks. Increasing referrals from hospitals and outpatient surgical centers are strengthening testing volumes. Automation of laboratory diagnostics is improving turnaround time while supporting consistent monitoring of patient blood parameters.

Patient Blood Management Market, By Geography

North America: North America dominates the patient blood management market, as strong hospital infrastructure and structured clinical guidelines are encouraging widespread adoption of blood conservation programs and transfusion monitoring systems. Healthcare providers are integrating advanced diagnostic and surgical technologies to reduce transfusion dependence. Boston, Massachusetts, maintains a strong concentration of leading hospitals and medical research institutions supporting innovation in transfusion medicine.

Europe: Europe is witnessing substantial growth in the patient blood management market, as regulatory healthcare frameworks and national transfusion guidelines are encouraging adoption of structured blood management protocols across hospitals. Integration of preoperative anemia management and restrictive transfusion practices is strengthening clinical implementation. Berlin, Germany acts as a leading healthcare hub supporting research collaboration and hospital adoption of modern blood management systems.

Asia Pacific: Asia Pacific is witnessing rapid expansion in the patient blood management market, as healthcare infrastructure modernization and increasing surgical procedure volumes are strengthening demand for advanced transfusion management systems. Governments are investing in hospital upgrades and blood bank digitization programs to improve clinical efficiency. Tokyo, Japan stands as a dominant medical innovation center supporting advanced transfusion medicine practices.

Latin America: Latin America is experiencing steady growth in the patient blood management market, as healthcare reforms and hospital modernization initiatives are improving access to diagnostic and transfusion management technologies. Expansion of surgical care services is increasing the need for efficient blood utilization frameworks. Sao Paulo, Brazil serves as a dominant healthcare and medical research center supporting regional adoption of patient blood management practices.

Middle East and Africa: The Middle East and Africa are witnessing gradual growth in the patient blood management market, as investments in hospital infrastructure and blood bank modernization are strengthening clinical capabilities across emerging healthcare systems. Expansion of trauma care and surgical services is increasing the importance of structured blood management programs. Dubai, United Arab Emirates, acts as a regional healthcare hub supporting advanced hospital technologies.

Key Players

• The competitive environment is remaining brand-driven, with established players leveraging distribution scale, product breadth, and brand trust. Competitive differentiation is shifting toward material transparency, comfort-led design, and sustainability positioning, while portfolio consolidation and brand acquisition activity are reshaping ownership dynamics.
• Key Players Operating in the Global Patient Blood Management Market
• Haemonetics Corporation
• Terumo Corporation
• Grifols S.A.
• Fresenius Kabi
• B. Braun SE
• Abbott Laboratories
• Siemens Healthineers
• Baxter International, Inc.
• Medtronic plc
• Stryker Corporation
• BioMerieux
• Immucor, Inc.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP-DOWN APPROACH
• 2.10 RESEARCH FLOW
• 2.11 DATA END USER

3 EXECUTIVE SUMMARY

• 3.1 GLOBAL PATIENT BLOOD MANAGEMENT MARKETOVERVIEW
• 3.2 GLOBAL PATIENT BLOOD MANAGEMENT MARKETESTIMATES AND FORECAST (USD BILLION)
• 3.3 GLOBAL PATIENT BLOOD MANAGEMENT MARKETECOLOGY MAPPING
• 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
• 3.5 GLOBAL PATIENT BLOOD MANAGEMENT MARKETABSOLUTE MARKET OPPORTUNITY
• 3.6 GLOBAL PATIENT BLOOD MANAGEMENT MARKETATTRACTIVENESS ANALYSIS, BY REGION
• 3.7 GLOBAL PATIENT BLOOD MANAGEMENT MARKETATTRACTIVENESS ANALYSIS, BY PRODUCT TYPE
• 3.8 GLOBAL PATIENT BLOOD MANAGEMENT MARKETATTRACTIVENESS ANALYSIS, BY COMPONENT
• 3.9 GLOBAL PATIENT BLOOD MANAGEMENT MARKETATTRACTIVENESS ANALYSIS, BY END USER
• 3.10 GLOBAL PATIENT BLOOD MANAGEMENT MARKETGEOGRAPHICAL ANALYSIS (CAGR %)
• 3.11 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT TYPE (USD BILLION)
• 3.12 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT (USD BILLION)
• 3.13 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER (USD BILLION)
• 3.14 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY GEOGRAPHY (USD BILLION)
• 3.15 FUTURE MARKET OPPORTUNITIES

4 MARKET OUTLOOK

• 4.1 GLOBAL PATIENT BLOOD MANAGEMENT MARKETEVOLUTION
• 4.2 GLOBAL PATIENT BLOOD MANAGEMENT MARKETOUTLOOK
• 4.3 MARKET DRIVERS
• 4.4 MARKET RESTRAINTS
• 4.5 MARKET TRENDS
• 4.6 MARKET OPPORTUNITY
• 4.7 PORTER'S FIVE FORCES ANALYSIS
  • 4.7.1 THREAT OF NEW ENTRANTS
  • 4.7.2 BARGAINING POWER OF SUPPLIERS
  • 4.7.3 BARGAINING POWER OF BUYERS
  • 4.7.4 THREAT OF SUBSTITUTE PRODUCT TYPES
  • 4.7.5 COMPETITIVE RIVALRY OF EXISTING COMPETITORS
• 4.8 VALUE CHAIN ANALYSIS
• 4.9 PRICING ANALYSIS
• 4.10 MACROECONOMIC ANALYSIS

5 MARKET, BY PRODUCT TYPE

• 5.1 OVERVIEW
• 5.2 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY PRODUCT TYPE
• 5.3 INSTRUMENTS
• 5.4 ACCESSORIES
• 5.5 REAGENTS & KITS

6 MARKET, BY COMPONENT

• 6.1 OVERVIEW
• 6.2 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY COMPONENT
• 6.3 WHOLE BLOOD & RED BLOOD CELLS
• 6.4 PLASMA

7 MARKET, BY END USER

• 7.1 OVERVIEW
• 7.2 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY END USER
• 7.3 HOSPITALS
• 7.4 BLOOD BANKS
• 7.5 DIAGNOSTIC CLINICS & PATHOLOGY LABS

8 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 ITALY
  • 8.3.5 SPAIN
  • 8.3.6 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 BRAZIL
  • 8.5.2 ARGENTINA
  • 8.5.3 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST AND AFRICA
  • 8.6.1 UAE
  • 8.6.2 SAUDI ARABIA
  • 8.6.3 SOUTH AFRICA
  • 8.6.4 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 KEY DEVELOPMENT STRATEGIES
• 9.3 COMPANY REGIONAL FOOTPRINT
• 9.4 ACE MATRIX
  • 9.4.1 ACTIVE
• 9.42 CUTTING EDGE
  • 9.4.3 EMERGING
  • 9.4.4 INNOVATORS

10 COMPANY PROFILES

• 10.1 OVERVIEW
• 10.2 HAEMONETICS CORPORATION
• 10.3 TERUMO CORPORATION
• 10.4 GRIFOLS S.A.
• 10.5 FRESENIUS KABI
• 10.6 B. BRAUN SE
• 10.7 ABBOTT LABORATORIES
• 10.8 SIEMENS HEALTHINEERS
• 10.9 BAXTER INTERNATIONAL, INC
• 10.10 MEDTRONIC PLC
• 10.11 STRYKER CORPORATION